KAMALESH RAO – Founder and Chief Executive Officer

  • Natural products chemist by training
  • 20+ years experience in Drug development, Implant development, and Product approvals.
  • Played a pivotal role in the development of Probuphine®, an implant able formulation approved by the USFDA to treat opioid addiction.

DR. SADHANA SATHAYE – Chief Scientific Officer

  • Professor of Pharmacology at Institute Of Chemical Technology
  • Ph.D. (Tech), Pharmacology
  • Research in Epilepsy, Parkinson’s and Alzheimer’s
  • Expert in pharmacokinetics and pharmacodynamics modeling
  • Authored 75 research publications

DR. VIDYA HEBBAR – Vice President, Product Development

  • Pharmacist Reg. in NY, CA and MD
  • Ph.D., Pharmaceutical Sciences, Univ. of Oklahoma
  • Research in the area of signal transduction mechanisms of cancer-chemo preventive agents

DEEPAK PINGALAY – Chief Operations Officer

  • Business Operations and Marketing Executive with focus on GTM, Scale and Growth Strategies and Partnerships Ecosystem Development
  • M.S. in Materials Science & Engineering
  • Serial Entrepreneur and Management Consultant.

DR. PURNIMA AMIN – Technology Consultant

  • Professor of Pharmacy at Institute Of Chemical Technology
  • Ph.D. (Tech), Pharmacy
  • Recognized industry expert in Hot Melt Extrusion (HME), solid dosage forms, and bioavailability enhancement

JEREMIAH F O’LEARY – Chief Financial Officer

  • CPA and ex-JP Morgan Leader
  • Board Member / Adviser for several organizations

DR. USHA NAYAK – Technology Advisor

  • Faculty at Manipal College of Pharmaceutical Sciences
  • PhD in Pharmaceutics
  • Expert in nano-pharmaceuticals, controlled drug delivery, and bioavailability enhancement

JOHNO’LEARY – Chief Legal Officer

  • General Counsel
  • Expert in securities laws, private to public, and compliance.